MYELOFIBROSIS side effect
What is MYELOFIBROSIS ?Drugs associated with MYELOFIBROSIS
ANAGRELIDE EFFEXOR EXJADE IMATINIB INTRON PROCRIT REVLIMID RITUXAN THALOMIDMYELOFIBROSIS : Rituxan Side Effects Report #5598371-6
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Jan 11, 2008. Male patient was diagnosed with haemolytic anaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, pancytopenia, . RITUXAN dosage: unknown. Patient recovered.
MYELOFIBROSIS : Effexor Side Effects Report #5565129-3
EFFEXOR problem was reported by a Health Professional from FRANCE on Dec 17, 2007. Female patient was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, pancytopenia, . EFFEXOR dosage: unknown. During the same period patient was treated with LEXOMIL, ABUFENE, BETASERC, SERMION, DOLIPRANE, TAHOR, AMYLASE. Patient was hospitalized. Patient recovered.
MYELOFIBROSIS : Exjade Side Effects Report #5448249-3
Consumer or non-health professional from UNITED STATES reported EXJADE problem on Sept 07, 2007. Female patient was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, platelet count decreased, . EXJADE dosage: unknown. Patient died on 05/01/2007.
MYELOFIBROSIS : Revlimid Side Effects Report #5671680-8
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, 80 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN D, ORAL. Patient died on 02/04/2008.
MYELOFIBROSIS : Anagrelide Side Effects Report #5688192-8
Physician from SWEDEN reported ANAGRELIDE HYDROCHLORIDE problem on Mar 12, 2008. Male patient was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with ANAGRELIDE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, platelet count decreased, . ANAGRELIDE HYDROCHLORIDE dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.
MYELOFIBROSIS : Revlimid Side Effects Report #5571116-1
REVLIMID problem was reported by a Physician from UNITED STATES on Dec 13, 2007. Male patient, 78 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL; 10 MG, IN 1 IN D, ORAL. Patient died on 11/09/2007.
MYELOFIBROSIS : Revlimid Side Effects Report #5483612-6
Physician from UNITED STATES reported REVLIMID problem on Oct 02, 2007. Female patient, 63 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, QD, ORAL. Patient died on 03/26/2007.
MYELOFIBROSIS : Imatinib Side Effects Report #5489047-4
IMATINIB problem was reported by a Health Professional from GERMANY on Oct 09, 2007. Male patient, 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, myelofibrosis, platelet count decreased, splenomegaly, white blood cell count increased, . IMATINIB dosage: 400 MG/D. Patient recovered.
MYELOFIBROSIS : Revlimid Side Effects Report #5453517-5
Health Professional from UNITED STATES reported REVLIMID problem on Sept 11, 2007. Male patient, 68 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2007.
MYELOFIBROSIS : Revlimid Side Effects Report #5471207-X
REVLIMID problem was reported by a Physician from UNITED STATES on Sept 20, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome, myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 08/01/2007.
MYELOFIBROSIS : Intron Side Effects Report #5379335-4
Consumer or non-health professional from UNITED STATES reported INTRON A problem on June 26, 2007. Female patient was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
MYELOFIBROSIS : Intron Side Effects Report #5396876-4
INTRON A problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient, 54 years of age, weighting 115.0 lb, was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
MYELOFIBROSIS : Intron Side Effects Report #5379335-4
Consumer or non-health professional from UNITED STATES reported INTRON A problem on June 26, 2007. Female patient was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
MYELOFIBROSIS : Intron Side Effects Report #5396876-4
INTRON A problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient, 54 years of age, weighting 115.0 lb, was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
MYELOFIBROSIS : Revlimid Side Effects Report #5635795-2
Health Professional from SPAIN reported REVLIMID problem on Feb 15, 2008. Male patient was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG,DAILY,ORAL. Patient died.
MYELOFIBROSIS : Procrit Side Effects Report #5592920-X
PROCRIT problem was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, bone marrow failure, myelofibrosis, thrombocytopenia, . PROCRIT dosage: unknown. During the same period patient was treated with ARANESP, TOPROL, FISH OIL, SINGULAIR, VITAMIN B6, DANAZOL, ACYCLOVIR, LIPITOR. Patient recovered.
MYELOFIBROSIS : Thalomid Side Effects Report #5481944-9
Physician from UNITED STATES reported THALOMID problem on Oct 02, 2007. Female patient, 54 years of age, was diagnosed with myelofibrosis and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: disease progression, malaise, myelofibrosis, polycythaemia, respiratory arrest, . THALOMID dosage: 50 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 09/07/2007.